This apparent inconsistency could be explained by the fact that higher CTLA4 expression in the early stages of HCV infection may be favorable for disease course as it could protect from overactivation of the immune response in the liver, but at the same time indicate robust immune response to infection [49]. This evidence concerns the gene CTLA4 and infection.